Aveanna Healthcare (NASDAQ:AVAH) Trading Down 4.8% - Time to Sell?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report)'s share price dropped 4.8% during trading on Wednesday . The company traded as low as $4.76 and last traded at $4.76. Approximately 79,756 shares traded hands during mid-day trading, a decline of 76% from the average daily volume of 336,774 shares. The stock had previously closed at $5.00.

Analysts Set New Price Targets

A number of analysts have recently issued reports on AVAH shares. UBS Group boosted their target price on Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a report on Friday, May 9th. Truist Financial decreased their price objective on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a research note on Friday, April 11th. Barclays started coverage on Aveanna Healthcare in a report on Wednesday. They issued an "equal weight" rating and a $5.50 price target for the company. Finally, Wall Street Zen lowered shares of Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 27th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, Aveanna Healthcare has a consensus rating of "Hold" and a consensus price target of $5.20.

Aveanna Healthcare Stock Up 3.7%

The company has a 50 day simple moving average of $5.16 and a 200-day simple moving average of $4.86. The stock has a market cap of $902.29 million, a price-to-earnings ratio of 231.25 and a beta of 1.98.

Insider Transactions at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of the firm's stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $5.36, for a total value of $8,365,352.00. Following the transaction, the insider owned 29,640,756 shares of the company's stock, valued at $158,874,452.16. This trade represents a 5.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Patrick A. Cunningham sold 18,500 shares of the company's stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $4.93, for a total value of $91,205.00. Following the transaction, the insider directly owned 327,869 shares of the company's stock, valued at $1,616,394.17. This trade represents a 5.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,115,345 shares of company stock valued at $37,838,057 over the last quarter. Insiders own 7.80% of the company's stock.

Institutional Trading of Aveanna Healthcare

Hedge funds have recently made changes to their positions in the stock. Banque Transatlantique SA acquired a new stake in Aveanna Healthcare in the first quarter worth $25,000. KLP Kapitalforvaltning AS acquired a new stake in shares of Aveanna Healthcare in the 4th quarter worth about $35,000. BNP Paribas Financial Markets acquired a new stake in shares of Aveanna Healthcare in the 4th quarter worth about $35,000. Tower Research Capital LLC TRC lifted its position in Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock valued at $36,000 after purchasing an additional 6,854 shares during the last quarter. Finally, Catalyst Funds Management Pty Ltd boosted its stake in Aveanna Healthcare by 321.4% during the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock valued at $54,000 after purchasing an additional 9,000 shares during the period. Institutional investors own 87.96% of the company's stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.